This Jan Aushadhi Campaign has already started with the opening of the first Jan aushadhi store at Amritsar on 25th November 2008 with the active participation of the CPSUs namely, IDPL,HAL,BPCL,KAPL & RDPL. With the launch of the Jan Aushadhi store at Shastri Bhavan, New Delhi, on 5th February, 2009, the campaign is reaching an ambitious phase of launching of more than 45 stores in the States of Andhra Pradesh, Delhi, Rajasthan, Maharashtra, Haryaa, Bihar, UP, Assam and Chattisgarh by March 2009.

Salius Pharma is an Indo-Canadian joint venture integrated Pharmaceutical company involved in manufacturing, trading, marketing and export of wide range of pharmaceutical Formulations, APIs, Nutraceuticals and Surgical and Herbal Products to many countries across the globe.

G.B. Pant Institute of Himalayan Environment and Development (GBPIHED) was established in 1988-89, during the birth centenary year of Bharat Ratna Pt. Govind Ballabh Pant, as an autonomous Institute of the Ministry of Environment and Forests (MoEF), Govt.

Agharkar Research Institute (ARI) is an autonomous, grant-in-aid research institute of the Department of Science and Technology (DST), Goverment of India. It was established in 1946 by the Maharashtra Association for the Cultivation of Science as MACS Research Institute and renamed as ARI in 1992 in honour and memory of its founder Director, late Professor S.P. Agharkar.

Walk-in-interview will be held to engage Para Medical Staff on contract basis for the period upto 30-06-2014 from the date of engagement as per details given below:-

Post: Pharmacist

Pharma MNC

Post: Head R&D

With a coastline of about 3,500 miles, inland sources in Rajasthan and Little Rann of Kutch, and the rock salt mines in Mandi, India have possibilities of attaining a high position in salt production among the salt producing countries of the world. As is known, apart from being an indispensable item of food, salt is an important raw material for the manufacture of several heavy chemicals e.g. soda ash, caustic soda and chlorine.

About Author:
Mridula Jayaraman,
Amity Institute of Pharmacy,
Amity University, India
mridulajayaraman1990@gmail.com

Abstract
The word ‘cancer’ itself sends chills down our spines as its prognosis and treatment, even if detected at an early stage is cumbersome and tortuous. With the advent of modern medicines, even though it is claimed that cancer is curable, there exists virtually no chemotherapeutic agent for cancer without side effect(s), not to mention the cost of these medicines which are skyrocketing.
Hence, we are left with little choice but to go for new fronts in research on the therapeutic agents present in plants (Phytotherapy), which are not only cost effective but also relatively side effects free.  These plants are available in plenty in the Himalayan and Aravali Region of India.  
University of Wisconsin lists 150 plants which they have established as having potential value in the treatment of cancer.  However, the real issue here is that not many drugs derived from plants have been standardized and standardization of these plants for therapeutic purpose is still in the nascent stage.

About Author:
Shambhavi Singh
M.pharma, Singhania University
Jhunjhunu, Rajasthan
Shambhavisingh6777@gmail.com

Abstract
Based on the figures from the World Health Organization, more than 20 lakhs women die worldwide because of cervical cancer per year. Cervical cancer, a potentially preventable disease, found as the second most common malignancy in women worldwide. In India, the disease accounts for a probable 24 percent of  India’s cancer cases among women and in addition to that 74,000 Indian women die annually from the disease, which results from the unusual growth of cells in the cervix. Cervical cancer is the most frequent disorder among women age near about 50 that increased the death rate  in  Indian rural women as compared urban due to lack awareness and don’t gain proper education. Cancer causing growth in the cervix is not a solitary type. It is not usually linked with hereditary genetic factor but a number of variable factors (Chemical, environmental and biological) indirectly enhance the risk of cervical cancer by increasing the possibility that a woman can contact an HPV infection. National Cancer Control Program emphasizes the significance of early detection and treatment. But our country has no well thought-out screening program and many women in India lack information regarding the disease and way to prevention and treatment facilities. Therefore, it is most of important to treat properly cervical cancer and make awareness in Indian women regarding its treatment and proper management.

The Jaypee Group of Companies has consistently displayed full awareness of its social responsibilities through the Jaiprakash Sewa Sansthan (JSS), a ‘not for profit’ Trust.

The Advanced Centre for Treatment, Research and Education in Cancer (ACTREC, Kharghar, Navi Mumbai is the new state-of-the-art R&D satellite of the Tata Memorial Centre (TMC), which also includes under its umbrella the Tata Memorial Hospital (TMH), the largest cancer hospital in Asia. ACTREC has the mandate to function as a national centre for treatment, research and education in cancer. TMC is an autonomous grant-in-aid institution of the Department of Atomic Energy (DAE), Government of India.

HLL Lifecare Limited, a Mini Ratna Central Public Sector Enterprise under the Ministry of Health & Family Welfare, Govt. of India is a global provider of high quality healthcare products & services.  With state-of-the-art manufacturing facilities spanning across India, HLL is diversifying into vaccine manufacturing, lifecare services, sanitary napkins besides engaging in procurement consultancy, healthcare, infrastructure development and facility management.

The National Institute of Oceanography (NIO) with its headquarters at Dona Paula, Goa, and regional centers at Kochi, Mumbai and Visakhapatnam, is one of the 38 constituent laboratories of the Council of Scientific & Industrial Research (CSIR), New Delhi. NIO was established on 1 January 1966 following the International Indian Ocean Expedition (IIOE) in early 1960s. The institute has grown today into a large oceanographic laboratory of international repute.

ICON is a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries. We specialize in the strategic development, management and analysis of programs that support Clinical Development – from compound selection to Phase I - IV clinical studies

HLL Lifecare Limited, a Mini Ratna Central Public Sector Enterprise under the Ministry of Health & Family Welfare, Govt. of India is a global provider of high quality healthcare products & services.  With state-of-the-art manufacturing facilities spanning across India, HLL is diversifying into vaccine manufacturing, lifecare services, sanitary napkins besides engaging in procurement consultancy, healthcare, infrastructure development and facility management.

Applications in the prescribed proforma are invited from eligible candidates for following posts under the Chief District Medical Officer, Koraput to be filled on contractual basis under regular & newly created post with monthly remuneration mentioned against each of the post.

Post: MPHW(M), Pharmacist

The PGIMER owes its inception to the vision of late Sardar Partap Singh Kairon, the then Chief Minister of Punjab and the distinguished medical educationists of the then combined state of Punjab, supported by the first Prime Minister of India Pt. Jawahar Lal Nehru who considered the institutions of scientific knowledge as temples of learning and the places of pilgrimage. The institute started in 1962 and Pt Jawahar Lal Nehru inaugurated the hospital now named “Nehru Hospital” on 7th July 1963.

Established in the year 1924 in India GlaxoSmithKline Pharmaceuticals Ltd. (GSK Rx India) is one of the oldest pharmaceuticals company and employs over 3500 people. Globally, we are a £ 26.4 billion, leading, research-based healthcare and pharmaceutical company. In India, we are one of the market leaders with a turnover of Rs. 3021 crore and a share of 4.2%*. At GSK, our mission is to improve the quality of life by enabling people to do more, feel better and live longer.